CSPC Ouyi Pharmaceutical Co., Ltd.

Quick facts

Phase 3 pipeline

• ABCD
  ABCD is an investigational drug in phase 3 development by CSPC Ouyi Pharmaceutical Co., Ltd., but its specific mechanism of action is not publicly disclosed.
• pregabalin sustained-release tablets
• SYHX1901
  SYHX1901 is a small molecule drug that targets the molecular target.
• SYHX2011 · Diabetes
  SYHX2011 is a small molecule drug that targets the SGLT2 receptor.

Phase 1 pipeline

• SYH2043
• SYHX 1901 tablets
• SYHX2005
• SYHX2011 and Abraxane®

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CSPC Ouyi Pharmaceutical Co., Ltd. portfolio CI brief
• CSPC Ouyi Pharmaceutical Co., Ltd. pipeline updates RSS